Physician profile
Michael A Parentis
NPI 1821054057
$9,658.78
in general payments reported to CMS, 2019-2025
22 companies · $786 in 2025
The $786 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $316 · 2020: $1,398 · 2021: $1,875 · 2022: $1,292 · 2023: $2,962 · 2024: $1,029 · 2025: $786.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,095 · Food and Beverage: $1,503 · Education: $180.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,095.14 |
| Food and Beverage | $1,502.98 |
| Education | $179.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $3,585.62 | 2019-2024 | Avenir, G7, Comprehensive Shoulder System |
| Prodigy Surgical Distribution, INC. | $3,049.69 | 2020-2025 | |
| Pacira Therapeutics, INC. | $566.68 | 2019-2021 | |
| Innovation Technologies INC | $371.58 | 2021-2022 | |
| Ferring Pharmaceuticals INC. | $318.85 | 2019-2025 | Euflexxa |
| Depuy Synthes Sales INC. | $273.35 | 2019-2025 | Monovisc, Orthovisc |
| Pacira Pharmaceuticals Incorporated | $251.81 | 2019-2022 | |
| Stryker Corporation | $227.57 | 2023-2025 | Inbone, Infinity Adaptis, Inspace |
| Arthrex, INC. | $206.40 | 2023 | |
| Smith+Nephew, INC. | $185.43 | 2019-2025 | Evos Mini, Evos, Lens 4k |
| Treace Medical Concepts, INC. | $137.08 | 2025 | |
| Fidia Pharma USA INC. | $97.32 | 2022-2025 | Hymovis, Triluron, Hyalgan |
| Vertex Pharmaceuticals Incorporated | $80.06 | 2025 | |
| Avanos Medical | $55.47 | 2019-2023 | Grpro 2.1 |
| Horizon Therapeutics Plc | $45.31 | 2019-2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $39.69 | 2022-2023 | Exogen Ultrasound Bone Healing System |
| Acera Surgical, INC. | $37.56 | 2025 | Restrata Wound Matrix |
| Abbott Laboratories | $35.29 | 2025 | Proclaim, Eterna |
| Curonix LLC | $31.39 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Integra Lifesciences Corporation | $24.17 | 2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Novo Nordisk INC | $19.83 | 2023 | Wegovy |
| Djo, LLC | $18.63 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Parentis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.